UniQure CFO To Leave; Names New COO

(RTTNews) - Netherlands-based uniQure N.V. (QURE), a biopharma company developing gene therapy, Wednesday said its Chief Financial Officer Piers Morgan resigned and will leave the company on May 20, to pursue other interests. The company also named Eric Goossens as its new Chief Operating Officer.

The company said Eric Goossens is joining the company from Datwyler Pharma Packaging Belgium N.V., and has 15 years of management experience in companies including biopharmaceutical industry.

uniQure also appointed Deya Corzo, M.D as Vice President, Medical Affairs for the United States with effect from April 1.